Respiratory Syncytial Virus Vaccine Effectiveness in Medicare Beneficiaries Residing in Nursing Homes
Listen to this summary
The authors aimed to assess the effectiveness of respiratory syncytial virus (RSV) vaccinations in preventing RSV-associated outcomes among Medicare beneficiaries living in nursing homes during the first season of the vaccine's availability. The study found that RSV vaccination was associated with significant reductions in hospitalizations (73% effectiveness), deaths (56% effectiveness), severe outcomes (59% effectiveness), and thromboembolic events (66% effectiveness) among this high-risk population. Overall, the findings indicate that RSV vaccines can improve health outcomes for nursing home residents.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from JAMA internal medicine
View all →Sep 21, 2026 · JAMA internal medicine
Steatotic Liver Disease Risk Scores to Predict Cirrhosis and Hepatocellular Carcinoma
Sep 14, 2026 · JAMA internal medicine
Effective Palliative Care for Hospice Transitions
Sep 8, 2026 · JAMA internal medicine
Menopausal Hormone Therapy and Cardiovascular Risk in Midlife Women With Vasomotor Symptoms
Sep 8, 2026 · JAMA internal medicine
Timing of Initiation of Methadone Take-Home Dosing
Aug 30, 2026 · JAMA internal medicine
Specialist Referral for Cardiovascular Risk in Patients With Prostate Cancer: A Randomized Clinical Trial
Aug 24, 2026 · JAMA internal medicine
Epidemiologic Study of Transfusion-Related Alpha-Gal Syndrome
More in Internal Medicine
View all →Sep 23, 2026 · JACC. Clinical electrophysiology
Programmed Ventricular Stimulation for Risk Stratification in Nonischemic Cardiomyopathy With Preserved or Mildly Reduced LVEF
Sep 23, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Five-Year Follow-Up of the Phase III ASCOT Trial of Adjuvant S-1 After Resection for Biliary Tract Cancer
Sep 23, 2026 · American journal of respiratory and critical care medicine
Biologic outcomes in severe asthma patients by smoking status: evidence from SHARP
Sep 23, 2026 · The New England journal of medicine
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Sep 23, 2026 · The New England journal of medicine
Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
Sep 23, 2026 · American journal of respiratory and critical care medicine
Combined results of the TETON-1 and TETON-2 Trials of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


